<code id='6E518EF2BD'></code><style id='6E518EF2BD'></style>
    • <acronym id='6E518EF2BD'></acronym>
      <center id='6E518EF2BD'><center id='6E518EF2BD'><tfoot id='6E518EF2BD'></tfoot></center><abbr id='6E518EF2BD'><dir id='6E518EF2BD'><tfoot id='6E518EF2BD'></tfoot><noframes id='6E518EF2BD'>

    • <optgroup id='6E518EF2BD'><strike id='6E518EF2BD'><sup id='6E518EF2BD'></sup></strike><code id='6E518EF2BD'></code></optgroup>
        1. <b id='6E518EF2BD'><label id='6E518EF2BD'><select id='6E518EF2BD'><dt id='6E518EF2BD'><span id='6E518EF2BD'></span></dt></select></label></b><u id='6E518EF2BD'></u>
          <i id='6E518EF2BD'><strike id='6E518EF2BD'><tt id='6E518EF2BD'><pre id='6E518EF2BD'></pre></tt></strike></i>

          Home / Wikipedia / hotspot

          hotspot


          hotspot

          author:leisure time    Page View:8881
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In